Showing results (1-10 of 88) with videos related to

Sort By:
Pageof 9
Hematology/Oncology Clinics of North America|November 30, 2013
Relapsed/refractory Hodgkin lymphoma: what is the best salvage therapy and do we need RIC-alloSCT?Mark Hertzberg
American Journal of Clinical Pathology|April 22, 2005
External quality assurance of DNA testing for thrombophilia mutationsMark Hertzberg, Sue Neville, Emmanuel Favaloro, et al.
The Australasian Journal of Dermatology|July 18, 2002
Stage IV CD30+ anaplastic large cell lymphoma: response to acitretin and interferon-alphaColin Ong, John Sullivan, Mark Hertzberg, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 20, 2010
The Clinical Impact of Infection with Swine Flu (H1N109) Strain of Influenza Virus in Hematopoietic Stem Cell Transplant RecipientsBiju George, Patricia Ferguson, Ian Kerridge, et al.
The Australasian Journal of Dermatology|December 16, 2014
Gemcitabine and vinorelbine treatment in cutaneous T-cell lymphoma in four patientsAzura Mohd Affandi, Tatiana Pinto Blumetti, Jillian Wells, et al.
American Journal of Clinical Pathology|June 24, 2003
Laboratory diagnosis of von Willebrand disorder. Current practice in the southern hemisphereEmmanuel J Favaloro, Roslyn Bonar, John Sioufi, et al.
Pathology|December 21, 2011
Evaluating laboratory approaches to the identification of lupus anticoagulants: a diagnostic challenge from the RCPA Haematology QAPRoslyn Bonar, Emmanuel Favaloro, Diane Zebeljan, et al.
Seminars in Thrombosis and Hemostasis|July 25, 2006
Reducing errors in identification of von Willebrand disease: the experience of the royal college of pathologists of australasia quality assurance programEmmanuel J Favaloro, Roslyn Bonar, Geoff Kershaw, et al.
British Journal of Haematology|September 27, 2014
Chronic lymphocytic leukaemia, monoclonal B-lymphocytosis and pregnancy: five cases, a literature review and discussion of managementNada Hamad, David Kliman, O Giles Best, et al.
British Journal of Haematology|October 8, 2019
Brentuximab vedotin for the treatment of patients with relapsed or refractory Hodgkin lymphoma after autologous stem cell transplantationPanayotis Kaloyannidis, Mark Hertzberg, Kate Webb, et al.
Pageof 9